Fully-funded PhD projects

Apply for our fully-funded PhD projects in subjects including chemistry, biology, computer science, and physics.

PhD opportunities for science graduates

Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish to be notified about future PhD opportunities. You can also view the recording of the 2023 Application Workshop, where we heard from our Academic Lead for Recruitment, Head of Research Degree Programmes and Researcher Development Manager. We also had advice and guidance from the University of London Careers Service, and an insight from some of our current PhD students at the ICR.

Stipends

The ICR's current student stipend is £26,050 per year. Studentships awarded by the Cancer Research UK Convergence Science Centre, which is a partnership of the ICR and Imperial College London, instead includes a stipend paid at the Cancer Research UK rate of £23,000 per year.

Find out about our application process

View 2023 application workshop recording

Application process flow diagram

Apply now

Available opportunities

You can view details of the projects we are currently advertising below. We will be adding further projects as soon as these are confirmed so please do check back regularly. Funding for our PhD projects comes from a variety of different sources, including some funded programmes, such as the MRC Doctoral Training Partnership. Please note, the advertised funder may change prior to registration.

Enhancing immune responses to radiation with spatiotemporal dose modulation and drug combinations

Primary Supervisor: Dr Magnus Dillon
Supervisory Team: Prof Uwe Oelfke
Primary Division and Team: Radiotherapy and Imaging, Biological enhancement of radiotherapy
Funded by: CRUK RadNet
Deadline: 24 November 2024

Fully-funded PhD projects

PhD opportunities for science graduates

Stipends

Available opportunities

Previous projects

Development of automatic plan-of-the-day selection tools for radiation therapy of pelvic cancer Professor Helen McNair

Advancing clinical elastography for early, non-invasive imaging assessment of normal tissue toxicity and tumour response Dr Jessica Winfield

Late-effects of hypofractionated radiotherapy for breast cancer Professor Amy Berrington

Investigating the cytoprotective role of the ectonucleotidase CD38 in immune responses to cancer Dr Erik Wennerberg

Role of the non-coding genome in the evolution of myeloma Dr Martin Kaiser

Resolving the isoform-specific signalling of RSK1 and RSK4 in non-small cell lung cancer through combined artificial intelligence and molecular biology Dr Anna Barnard

Resolving the isoform-specific signalling of RSK1 and RSK4 in non-small cell lung cancer through combined artificial intelligence and molecular biology Dr Olivier Pardo

Fluorescent nanoparticle arrays for label-free monitoring of immunotherapy for bladder cancer Dr Anna Wilkins

Machine and deep learning for improving photoacoustic imaging for CAR T-cell cancer therapy Professor Jeff Bamber (ICR)/Lucia Florescu (Surrey)

Investigating the functions of histone acetylation in genome organization and leukemogenesis Dr Alex Radzisheuskaya

Exploiting intercellular interactions to overcome prostate cancer cell states cooperation and plasticity Dr Marco Bezzi

Comprehensive multi-omic analyses of “islands of resistance” tumour cells to identify aromatase inhibitor resistant subclones in oestrogen receptor positive breast cancer Dr Maggie Cheang

Targeting cancer cell dependency on RNA-binding proteins Dr Paul Clarke

Understanding the mechanisms underpinning therapeutic vulnerability of SWI/SNF deficient cancers Professor Jessica Downs

Computational genomics and epigenomics to understand metastasis Professor Trevor Graham

In situ analysis of the TCR repertoire in colorectal cancer Professor Trevor Graham

Structural and functional studies of the regulation of mRNA splicing by cyclin-dependent kinases Dr Basil Greber

Development of tankyrase-directed PROTACs as novel scaffolding inhibitors Professor Sebastian Guettler

Tracking immune cell migration in tumour and normal tissues after combined radiation-drug therapy in Kaede mice Professor Kevin Harrington

Developing new therapeutic strategies for ALT positive sarcomas Dr Paul Huang

Integrative spatial proteomic analysis of tumour microenvironment response to therapy in sarcomas Dr Paul Huang

Modelling and targeting the effects of EGFR on diffusely infiltrating paediatric high-grade gliomas or midline and cerebral regions Professor Chris Jones/Dr Julia Cockle

Identifying molecular pathways of drug resistance in multiple myeloma Dr Martin Kaiser

Exploring the differences in the structural characterisation of inhibitor binding between cryo- and room-temperature using multicrystal X-ray crystallography Dr Rob van Montfort

Evaluation of sub-clonal alterations mediating response and resistance to CDK7 inhibition in therapy resistant triple negative breast cancer Dr Rachael Natrajan

Identifying therapeutical opportunities within replicative stress response pathways for the development of novel therapeutic strategies to treat cancer Professor Wojciech Nidzwiedz

Structural investigation of spliceosomes hijacked by oncolytic viruses Professor Vlad Pena

Innate-immune drivers of cell fate during genotoxic stress Dr Christian Zierhut

Targeting RNA helicases to suppress aberrant androgen receptor expression and abrogate persistent androgen receptor signalling in lethal prostate cancer Dr Adam Sharp

Development of a patient model for real-time MRI guided radiotherapy of pancreas and liver cancer Professor Uwe Oelfke

Charting colorectal cancer interactomes at structural resolution using chemical crosslinking and mass spectrometry Professor Jyoti Choudhary

Development of novel dual-target agents to treat neuroblastoma that combine selective protein degradation with synergistic inhibition Professor Hector Keun (Imperial)

Unravelling the role of cancer associated fibroblasts in cancer evolution and drug resistance using microfluidics Professor Udai Banerji

An explant-in-chip platform to study immune-cancer cell interactions and enhance tumour immunogenicity ex vivo: a focus on radiotherapy Professor Darryl Overby (Imperial)

Deciphering the metabolic determinants of bone metastasis in breast cancer Dr George Poulogiannis

Composition and function of telomeric multi-protein complexes and their regulation by ADP-ribosylation Dr Sebastian Guettler

Dissecting the prostate cancer-stromal interface Prof Johann de Bono

Can artificial intelligence predict outcome in patients receiving stereotactic radiosurgery of brain metastasis? Dr Matthew Blackledge

Single-cell transcriptomics linked to lineage tracing to interrogate the role of “plasticity first” as a positive force driving paediatric cancer evolution Dr Alejandra Bruna

Exploring strategies for targeting oncogenic beta-catenin Dr Paul Clarke

Examining the mechanism of chromatin replication and assembly at telomeres Dr Max Douglas

Generation of mouse models to identify and characterize novel therapeutic targets in chemo refractory AML disease Professor Kristian Helin

Developing innovative chemical tools to drive lytic cancer cell death Prof Swen Hoelder

PET imaging to monitor immune cell fitness post-targeted treatment in GBM Dr Gabriela Kramer-Marek

Understanding PolØ and ATR inhibitor sensitivity in cancer Prof Chris Lord

Harnessing immunogenic cell death mechanisms to trigger anti tumour immunity Prof Pascal Meier

Identifying small molecules that bind to the E3-ligase Cbl-b Dr Gary Newton

Understanding myeloma cell – microenvironment interactions and their role in immunomodulatory drug resistance Dr Charlotte Pawlyn

Using lattice light sheet microscopy to determine how the Spindle Assembly Checkpoint turns off Prof Jon Pines

Advanced multiparametric MRI for the characterisation of soft tissue sarcoma and response to neoadjuvant therapy Dr Simon Robinson

Applying for a PhD

Why study at the ICR?

In this section

Related news

Cancer charity founder and cancer genetics pioneer honoured at ICR graduation ceremony

Discovery Club members meet next generation of cancer researchers

Related blogs

Science Talk

08 November

Science Talk

10 November

Science Talk

05 February

Related videos

What is the best thing about studying for a PhD at the ICR?

ICR values

Development of automatic plan-of-the-day selection tools for radiation therapy of pelvic cancer
Professor Helen McNair

Advancing clinical elastography for early, non-invasive imaging assessment of normal tissue toxicity and tumour response
Dr Jessica Winfield

Late-effects of hypofractionated radiotherapy for breast cancer
Professor Amy Berrington

Investigating the cytoprotective role of the ectonucleotidase CD38 in immune responses to cancer
Dr Erik Wennerberg

Role of the non-coding genome in the evolution of myeloma
Dr Martin Kaiser

Resolving the isoform-specific signalling of RSK1 and RSK4 in non-small cell lung cancer through combined artificial intelligence and molecular biology
Dr Anna Barnard

Resolving the isoform-specific signalling of RSK1 and RSK4 in non-small cell lung cancer through combined artificial intelligence and molecular biology
Dr Olivier Pardo

Fluorescent nanoparticle arrays for label-free monitoring of immunotherapy for bladder cancer
Dr Anna Wilkins

Machine and deep learning for improving photoacoustic imaging for CAR T-cell cancer therapy
Professor Jeff Bamber (ICR)/Lucia Florescu (Surrey)

Investigating the functions of histone acetylation in genome organization and leukemogenesis
Dr Alex Radzisheuskaya

Exploiting intercellular interactions to overcome prostate cancer cell states cooperation and plasticity
Dr Marco Bezzi

Comprehensive multi-omic analyses of “islands of resistance” tumour cells to identify aromatase inhibitor resistant subclones in oestrogen receptor positive breast cancer
Dr Maggie Cheang

Targeting cancer cell dependency on RNA-binding proteins
Dr Paul Clarke

Understanding the mechanisms underpinning therapeutic vulnerability of SWI/SNF deficient cancers
Professor Jessica Downs

Computational genomics and epigenomics to understand metastasis
Professor Trevor Graham

In situ analysis of the TCR repertoire in colorectal cancer
Professor Trevor Graham

Structural and functional studies of the regulation of mRNA splicing by cyclin-dependent kinases
Dr Basil Greber

Development of tankyrase-directed PROTACs as novel scaffolding inhibitors
Professor Sebastian Guettler

Tracking immune cell migration in tumour and normal tissues after combined radiation-drug therapy in Kaede mice
Professor Kevin Harrington

Developing new therapeutic strategies for ALT positive sarcomas
Dr Paul Huang

Integrative spatial proteomic analysis of tumour microenvironment response to therapy in sarcomas
Dr Paul Huang

Modelling and targeting the effects of EGFR on diffusely infiltrating paediatric high-grade gliomas or midline and cerebral regions
Professor Chris Jones/Dr Julia Cockle

Identifying molecular pathways of drug resistance in multiple myeloma
Dr Martin Kaiser

Exploring the differences in the structural characterisation of inhibitor binding between cryo- and room-temperature using multicrystal X-ray crystallography
Dr Rob van Montfort

Evaluation of sub-clonal alterations mediating response and resistance to CDK7 inhibition in therapy resistant triple negative breast cancer
Dr Rachael Natrajan

Identifying therapeutical opportunities within replicative stress response pathways for the development of novel therapeutic strategies to treat cancer
Professor Wojciech Nidzwiedz

Structural investigation of spliceosomes hijacked by oncolytic viruses
Professor Vlad Pena

Innate-immune drivers of cell fate during genotoxic stress
Dr Christian Zierhut

Targeting RNA helicases to suppress aberrant androgen receptor expression and abrogate persistent androgen receptor signalling in lethal prostate cancer
Dr Adam Sharp

Development of a patient model for real-time MRI guided radiotherapy of pancreas and liver cancer
Professor Uwe Oelfke

Charting colorectal cancer interactomes at structural resolution using chemical crosslinking and mass spectrometry
Professor Jyoti Choudhary

Development of novel dual-target agents to treat neuroblastoma that combine selective protein degradation with synergistic inhibition
Professor Hector Keun (Imperial)

Unravelling the role of cancer associated fibroblasts in cancer evolution and drug resistance using microfluidics
Professor Udai Banerji

An explant-in-chip platform to study immune-cancer cell interactions and enhance tumour immunogenicity ex vivo: a focus on radiotherapy
Professor Darryl Overby (Imperial)

Deciphering the metabolic determinants of bone metastasis in breast cancer
Dr George Poulogiannis

Composition and function of telomeric multi-protein complexes and their regulation by ADP-ribosylation
Dr Sebastian Guettler

Dissecting the prostate cancer-stromal interface
Prof Johann de Bono

Can artificial intelligence predict outcome in patients receiving stereotactic radiosurgery of brain metastasis?
Dr Matthew Blackledge

Single-cell transcriptomics linked to lineage tracing to interrogate the role of “plasticity first” as a positive force driving paediatric cancer evolution
Dr Alejandra Bruna

Exploring strategies for targeting oncogenic beta-catenin
Dr Paul Clarke

Examining the mechanism of chromatin replication and assembly at telomeres
Dr Max Douglas

Generation of mouse models to identify and characterize novel therapeutic targets in chemo refractory AML disease
Professor Kristian Helin

Developing innovative chemical tools to drive lytic cancer cell death
Prof Swen Hoelder

PET imaging to monitor immune cell fitness post-targeted treatment in GBM
Dr Gabriela Kramer-Marek

Understanding PolØ and ATR inhibitor sensitivity in cancer
Prof Chris Lord

Harnessing immunogenic cell death mechanisms to trigger anti tumour immunity
Prof Pascal Meier

Identifying small molecules that bind to the E3-ligase Cbl-b
Dr Gary Newton

Understanding myeloma cell – microenvironment interactions and their role in immunomodulatory drug resistance
Dr Charlotte Pawlyn

Using lattice light sheet microscopy to determine how the Spindle Assembly Checkpoint turns off
Prof Jon Pines

Advanced multiparametric MRI for the characterisation of soft tissue sarcoma and response to neoadjuvant therapy
Dr Simon Robinson

Related blogs

Related videos

ICR values